Aimovig (erenumab)

pCPA File Number: 21286
Negotiation Status:
Under consideration for negotiation
Indication(s):
migraine, chronic
Sponsor/Manufacturer:
NOVARTIS PHARMACEUTICALS CANADA INC
CADTH Project Number:
SR0578-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable